GLP-1 drugs are synthetic versions of glucagon-like peptide-1 - a hormone your body already makes to regulate blood sugar and appetite
Whether that closes the gap to retatrutide depends on the actual data, but the strategic logic adding a second mechanism to semaglutide because semaglutide alone can no longer compete on efficacy is now obvious
Semaglutide and tirzepatide have different side effect profiles , and tirzepatide acts on both GIP and GLP-1 receptors while semaglutide targets GLP-1 alone
Storage, Disposal, and When to Seek Medical Advice Follow your trial protocol for storage
Together they reduce appetite, smooth post-meal blood sugar spikes, and nudge the body to use more stored fat for energy
So, you really wont fully know what it feels like to be on any certain dose until you get to about that four-week mark